Microcrystalline is a chemically inert refined wood pulp that is widely utilized in the culinary, pharmaceutical, cosmetic, and polymer composite sectors. Its non-toxicity, renewability, biodegradability, and mechanical features including high surface area and biocompatibility all contribute to this. It's utilized as an emulsifier, stabilizer, anti-caking agent, texture modifier, stabilizer, fat substitute, and suspending agent in processed foods.
The increasing use of the Microcrystalline Cellulose Market in various sectors is one of the primary factors driving the global microcrystalline cellulose market forward. Microcrystalline cellulose, for example, is used in beverages as a stabilizer, gelling agent, suspending agent, an anti-caking agent. It's also used in frozen food, ice cream, and canned meat as a cold and hot stabilizer to extend the shelf life of the product. Furthermore, due to its tasteless, odorless, and chemical inert qualities, Microcrystalline Cellulose Market is commonly utilized in pharmaceuticals. The worldwide pharmaceutical market is expected to rise from roughly US$ 1 trillion in 2015 to US$ 1.3 trillion by 2020, according to the International Trade Administration, with an annual growth rate of 4.9 percent.
Over the forecast period, the gradually rising pharmaceutical industry is expected to boost the market expansion of microcrystalline cellulose. High production costs and low production yield, on the other hand, are important roadblocks to the market's expansion.
Because of the increasing use of the Microcrystalline Cellulose Market in pharmaceuticals, the pharmaceutical category accounted for the largest proportion of the market in 2016. Its chemical inertness and dry binding capabilities account for this. Furthermore, the worldwide microcrystalline cellulose market is predicted to increase significantly throughout the forecast period in the food and beverage industry. This is due to MCC's widespread use in sweets, frozen foods, dairy products, and baked goods, among other foods and beverages. It also serves as a fat substitute and aids in the preservation of food consistency.
In terms of revenue, North America dominated the global microcrystalline cellulose market in 2016, accounting for 30.47 percent of the market. This can be attributable to the constantly developing food and pharmaceutical industries, as microcrystalline cellulose is widely employed as a functional ingredient in food and beverages and has a high penetration in pharmaceuticals. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) predicts that the United States' share of the global pharmaceutical business will rise from 40.3 percent in 2015 to 40 percent in 2020.
In the global microcrystalline cellulose market, Asia Pacific is expected to develop at the fastest rate, with a CAGR of 7.33 percent over the forecast period. The market's expansion is being aided by the region's rapidly expanding food and pharmaceutical industries. The continually expanding geriatric population in the Asia Pacific is driving up demand for pharmaceutical items. According to the World Bank, East Asia has a higher elderly population growth rate than the rest of Asia Pacific. In 2010, East Asia's geriatric population totaled over 211 million people, with China accounting for roughly 130 million of them.
Major players operating in the global microcrystalline cellulose market include FMC Corporation, Asahi Kasei Corporation, Juku Orchem Private Limited, Mingtai Chemical Co. Ltd., Blanver, J Rettenmaier & Shone GmbH + Co Kg, Singachi Industries Pvt. Ltd., Accent Microcell Pvt. Ltd., and DFE Pharma.
0 Comments